Craneware plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CRWRF research report →
Companywww.thecranewaregroup.com
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors. It also offers InSight Denials to analyze, track, trend, and report on denial data; Trisus Healthcare Intelligence, a solution that provides insights into resource consumption on the patient level; Trisus Medication Analytic solutions; and Trisus supplies assistant solutions.
- CEO
- Keith Neilson
- IPO
- 2012
- Employees
- 747
- HQ
- Edinburgh, GB
Price Chart
Valuation
- Market Cap
- $828.54M
- P/E
- 30.29
- P/S
- 3.14
- P/B
- 2.01
- EV/EBITDA
- 13.69
- Div Yield
- 2.31%
Profitability
- Gross Margin
- 78.02%
- Op Margin
- 13.56%
- Net Margin
- 10.63%
- ROE
- 6.65%
- ROIC
- 6.10%
Growth & Income
- Revenue
- $205.66M · 8.66%
- Net Income
- $19.66M · 68.02%
- EPS
- $0.56 · 64.71%
- Op Income
- $25.25M
- FCF YoY
- 138.53%
Performance & Tape
- 52W High
- $34.00
- 52W Low
- $24.20
- 50D MA
- $26.72
- 200D MA
- $29.11
- Beta
- -0.17
- Avg Volume
- 50
Get TickerSpark's AI analysis on CRWRF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CRWRF Coverage
We haven't published any research on CRWRF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CRWRF Report →